Agribusiness giant Monsanto is appealing a $78 million verdict in favor of a dying California man who said the company's widely used Roundup weed killer was a major factor in his cancer.
The company filed a notice of appeal Tuesday in San Francisco Superior Court challenging the August jury verdict in favor of DeWayne Johnson.
Bayer, which acquired Monsanto in June, said in a statement that none of the science presented at trial supports the conclusion that Roundup was a substantial cause of Johnson's non-Hodgkin's lymphoma.
An email to a spokeswoman for Johnson's attorneys was not immediately returned.
Bayer says numerous studies have shown glyphosate, the active ingredient in the weed killer, is safe when used properly.